Abivax S.A. buy melinda
Start price
27.01.19
/
50%
€11.04
Target price
29.07.19
€16.00
Performance (%)
-13.50%
End price
29.07.19
€9.55
Summary
This prediction ended on 29.07.19 with a price of €9.55. The price of Abivax S.A. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.50%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Abivax S.A. | - | - | - | - |
iShares Core DAX® | 1.662% | 4.835% | 17.361% | 19.329% |
iShares Nasdaq 100 | 0.667% | 0.000% | 38.234% | 55.157% |
iShares Nikkei 225® | -2.139% | -4.786% | 13.099% | 7.393% |
iShares S&P 500 | 0.564% | 0.775% | 29.181% | 46.527% |
According to melinda what are the pros and cons of Abivax S.A. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by melinda for this prediction
In the thread Abivax S.A. diskutieren
Secteur Recherche biotechnologique et médicale Agenda 30/01 | 12:30 Investor Meeting
métier
Abivax est une société de biotechnologie spécialisée dans le ciblage du système immunitaire pour éliminer les maladies virales. Le groupe dispose de trois plateformes technologiques: une plateforme «antivirale», «stimulation immunitaire» et «anticorps polyclonaux». Phase II study afin de devenir un élément de guérison du VIH / SIDA. ABX464 est une nouvelle molécule administrée par voie orale qui inhibe la réplication virale via un mode d'action unique et qui présente un fort effet anti-inflammatoire. Abivax est également immuno-stimulant en phase clinique. (Chikungunya, Ebola, Dengue, etc.).
Nombre d'employés : 24 personnes.
(Laufzeit überschritten)
Stopped prediction by melinda for Abivax S.A.
Abivax S.A.
Start price
Target price
Perf. (%)
€9.10
04.08.22
04.08.22
-
04.08.23
04.08.23
81.32%
05.08.23
05.08.23
Could be very worthwhile Investment >20% year
Abivax S.A.
Start price
Target price
Perf. (%)
€9.85
07.11.19
07.11.19
€28.00
04.11.21
04.11.21
184.77%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Abivax S.A.
Start price
Target price
Perf. (%)
€8.60
21.12.17
21.12.17
€15.00
21.06.18
21.06.18
-19.53%
21.06.18
21.06.18
Could be very worthwhile Investment >20% year
Abivax S.A.
Start price
Target price
Perf. (%)
€6.00
17.02.17
17.02.17
€10.00
03.04.17
03.04.17
17.33%
03.04.17
03.04.17
Could be very worthwhile Investment >20% year
Abivax S.A.
Start price
Target price
Perf. (%)
€10.80
26.04.16
26.04.16
€20.00
26.10.16
26.10.16
-29.35%
26.10.16
26.10.16
Could be very worthwhile Investment >20% year